PHASES Score for Prediction of Intracranial Aneurysm Growth
BACKGROUND AND PURPOSE—Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also pr...
Saved in:
Published in | Stroke (1970) Vol. 46; no. 5; pp. 1221 - 1226 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.05.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | BACKGROUND AND PURPOSE—Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth.
METHODS—In a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles.
RESULTS—We included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5–10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22–1.43). With the lowest quartile of the PHASES score (0–1) as reference, hazard ratios were for the second (PHASES 2–3) 1.07 (95% CI, 0.49–2.32), the third (PHASES 4) 2.29 (95% CI, 1.05–4.95), and the fourth quartile (PHASES 5–14) 2.85 (95% CI, 1.43–5.67).
CONCLUSIONS—Higher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture. |
---|---|
AbstractList | BACKGROUND AND PURPOSEGrowth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth.METHODSIn a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles.RESULTSWe included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5-10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22-1.43). With the lowest quartile of the PHASES score (0-1) as reference, hazard ratios were for the second (PHASES 2-3) 1.07 (95% CI, 0.49-2.32), the third (PHASES 4) 2.29 (95% CI, 1.05-4.95), and the fourth quartile (PHASES 5-14) 2.85 (95% CI, 1.43-5.67).CONCLUSIONSHigher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture. Background and Purpose— Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth. Methods— In a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles. Results— We included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5–10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22–1.43). With the lowest quartile of the PHASES score (0–1) as reference, hazard ratios were for the second (PHASES 2–3) 1.07 (95% CI, 0.49–2.32), the third (PHASES 4) 2.29 (95% CI, 1.05–4.95), and the fourth quartile (PHASES 5–14) 2.85 (95% CI, 1.43–5.67). Conclusions— Higher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture. Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth. In a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles. We included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5-10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22-1.43). With the lowest quartile of the PHASES score (0-1) as reference, hazard ratios were for the second (PHASES 2-3) 1.07 (95% CI, 0.49-2.32), the third (PHASES 4) 2.29 (95% CI, 1.05-4.95), and the fourth quartile (PHASES 5-14) 2.85 (95% CI, 1.43-5.67). Higher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture. BACKGROUND AND PURPOSE—Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth. METHODS—In a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles. RESULTS—We included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5–10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22–1.43). With the lowest quartile of the PHASES score (0–1) as reference, hazard ratios were for the second (PHASES 2–3) 1.07 (95% CI, 0.49–2.32), the third (PHASES 4) 2.29 (95% CI, 1.05–4.95), and the fourth quartile (PHASES 5–14) 2.85 (95% CI, 1.43–5.67). CONCLUSIONS—Higher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture. |
Author | Tiel Groenestege, Andreas T Backes, Daan Greving, Jacoba P van Walderveen, Marianne A.A Velthuis, Birgitta K Rinkel, Gabriel J.E Vergouwen, Mervyn D.I Bor, A. Stijntje E Algra, Ale Agid, Ronit Wermer, Marieke J.H terBrugge, Karel G |
AuthorAffiliation | From the Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus (D.B., M.D.I.V., A.T.T.G., A.S.E.B., A.A., G.J.E.R.), Department of Radiology (B.K.V.), and Julius Center for Health Sciences and Primary Care (J.P.G., A.A.), University Medical Center Utrecht, Utrecht, the Netherlands; Departments of Neurology (M.J.H.W.) and Radiology (M.A.A.v.W.), Leiden University Medical Center, Leiden, the Netherlands; and Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, Toronto, Canada (K.G.t.B., R.A.) |
AuthorAffiliation_xml | – name: From the Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus (D.B., M.D.I.V., A.T.T.G., A.S.E.B., A.A., G.J.E.R.), Department of Radiology (B.K.V.), and Julius Center for Health Sciences and Primary Care (J.P.G., A.A.), University Medical Center Utrecht, Utrecht, the Netherlands; Departments of Neurology (M.J.H.W.) and Radiology (M.A.A.v.W.), Leiden University Medical Center, Leiden, the Netherlands; and Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, Toronto, Canada (K.G.t.B., R.A.) |
Author_xml | – sequence: 1 givenname: Daan surname: Backes fullname: Backes, Daan organization: From the Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus (D.B., M.D.I.V., A.T.T.G., A.S.E.B., A.A., G.J.E.R.), Department of Radiology (B.K.V.), and Julius Center for Health Sciences and Primary Care (J.P.G., A.A.), University Medical Center Utrecht, Utrecht, the Netherlands; Departments of Neurology (M.J.H.W.) and Radiology (M.A.A.v.W.), Leiden University Medical Center, Leiden, the Netherlands; and Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, Toronto, Canada (K.G.t.B., R.A.) – sequence: 2 givenname: Mervyn surname: Vergouwen middlename: D.I fullname: Vergouwen, Mervyn D.I – sequence: 3 givenname: Andreas surname: Tiel Groenestege middlename: T fullname: Tiel Groenestege, Andreas T – sequence: 4 givenname: A. Stijntje surname: Bor middlename: E fullname: Bor, A. Stijntje E – sequence: 5 givenname: Birgitta surname: Velthuis middlename: K fullname: Velthuis, Birgitta K – sequence: 6 givenname: Jacoba surname: Greving middlename: P fullname: Greving, Jacoba P – sequence: 7 givenname: Ale surname: Algra fullname: Algra, Ale – sequence: 8 givenname: Marieke surname: Wermer middlename: J.H fullname: Wermer, Marieke J.H – sequence: 9 givenname: Marianne surname: van Walderveen middlename: A.A fullname: van Walderveen, Marianne A.A – sequence: 10 givenname: Karel surname: terBrugge middlename: G fullname: terBrugge, Karel G – sequence: 11 givenname: Ronit surname: Agid fullname: Agid, Ronit – sequence: 12 givenname: Gabriel surname: Rinkel middlename: J.E fullname: Rinkel, Gabriel J.E |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25757900$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kF1LwzAUhoNM3Kb-A5FeetOZpOlH8KqMuQ0HG3ZelyQ9YdWumUnL2L-30rlLrw4Hnvc9h2eMBrWpAaEHgieEROQ5276v32bpIu1WNsE4ITy5QiMSUuaziCYDNMI44D5lnA_R2LlPjDENkvAGDWkYhzHHeIReNos0m2VepowFTxvrbSwUpWpKU3tGe8u6sUJZUZei8tIaWntye29uzbHZ3aFrLSoH9-d5iz5eZ9vpwl-t58tpuvJV2P3ky0QEEXDNmVKxpFwVCgoOgZIcMCmYpMBiTaJAKyl5rITEEAWc00hLyhQLbtFT33uw5rsF1-T70imoKlGDaV1OojgKOWUx7VDWo8oa5yzo_GDLvbCnnOD8V1t-0datLO-1dbHH84VW7qG4hP48dUDSA0dTNWDdV9UeweY7EFWz-7_7ByV0fM4 |
CitedBy_id | crossref_primary_10_1007_s00330_023_10388_7 crossref_primary_10_1016_j_wneu_2023_03_138 crossref_primary_10_1161_STROKEAHA_115_012162 crossref_primary_10_1007_s00701_024_05901_w crossref_primary_10_3389_fneur_2021_590751 crossref_primary_10_1007_s00062_017_0640_6 crossref_primary_10_3171_2021_6_JNS204155 crossref_primary_10_1186_s40001_024_01888_3 crossref_primary_10_1016_j_jocn_2023_07_025 crossref_primary_10_3389_fneur_2017_00451 crossref_primary_10_3340_jkns_2020_0144 crossref_primary_10_1177_0300060516671600 crossref_primary_10_1093_neuros_nyz311 crossref_primary_10_3171_2019_4_FOCUS1987 crossref_primary_10_16977_cbfm_30_1_35 crossref_primary_10_1016_j_nec_2017_02_006 crossref_primary_10_1021_acs_chemmater_0c00208 crossref_primary_10_1038_nrneurol_2015_146 crossref_primary_10_3389_fneur_2022_818335 crossref_primary_10_1016_j_inat_2020_100920 crossref_primary_10_3389_fphys_2021_644349 crossref_primary_10_3171_2017_3_JNS162984 crossref_primary_10_1080_02688697_2021_1995587 crossref_primary_10_1016_j_clineuro_2021_106877 crossref_primary_10_1371_journal_pone_0264616 crossref_primary_10_3174_ajnr_A8058 crossref_primary_10_3174_ajnr_A5341 crossref_primary_10_1097_MD_0000000000028696 crossref_primary_10_1161_SVIN_123_000625 crossref_primary_10_3174_ajnr_A6080 crossref_primary_10_1136_neurintsurg_2020_016811 crossref_primary_10_1159_000517421 crossref_primary_10_3171_2018_11_JNS181814 crossref_primary_10_1007_s10143_024_02408_x crossref_primary_10_1136_neurintsurg_2020_016654 crossref_primary_10_1016_j_medengphy_2019_09_010 crossref_primary_10_1177_1756286420987939 crossref_primary_10_1016_j_wneu_2017_11_093 crossref_primary_10_1097_01_CNE_0000482104_64218_a4 crossref_primary_10_1007_s11886_016_0763_4 crossref_primary_10_1161_STROKEAHA_117_017391 crossref_primary_10_1177_1747493018790033 crossref_primary_10_1177_15910199231201520 crossref_primary_10_1016_j_ijsu_2019_07_023 crossref_primary_10_1016_j_wneu_2019_07_163 crossref_primary_10_1007_s10143_020_01407_y crossref_primary_10_7887_jcns_29_101 crossref_primary_10_1016_j_cmpb_2022_107237 crossref_primary_10_1161_STROKEAHA_118_021030 crossref_primary_10_1016_j_neurol_2017_05_004 crossref_primary_10_1136_jnis_2022_019905 crossref_primary_10_1016_j_jstrokecerebrovasdis_2023_107052 crossref_primary_10_1016_j_wneu_2020_12_041 crossref_primary_10_1212_WNL_0000000000010997 crossref_primary_10_3171_2018_5_JNS18322 crossref_primary_10_1055_a_2291_5230 crossref_primary_10_3174_ajnr_A7865 crossref_primary_10_1055_a_1532_9244 crossref_primary_10_1007_s12975_017_0560_4 crossref_primary_10_1007_s00701_017_3239_4 crossref_primary_10_1055_s_0043_1763528 crossref_primary_10_3174_ajnr_A7186 crossref_primary_10_1038_nrneurol_2016_150 crossref_primary_10_3389_fcvm_2022_900647 crossref_primary_10_7326_M17_0246 crossref_primary_10_1177_1971400916638357 crossref_primary_10_1016_j_wneu_2019_09_103 crossref_primary_10_1007_s11548_022_02818_6 crossref_primary_10_1007_s13167_023_00315_7 crossref_primary_10_3389_fneur_2021_619864 crossref_primary_10_1016_j_wneu_2019_12_127 crossref_primary_10_1177_1358863X18754693 crossref_primary_10_1016_j_compbiomed_2022_105740 crossref_primary_10_1134_S0021894422020080 crossref_primary_10_1186_s12938_019_0657_y crossref_primary_10_1136_neurintsurg_2016_012295 crossref_primary_10_1016_j_inat_2018_02_003 crossref_primary_10_1016_j_clineuro_2021_106949 crossref_primary_10_1136_jnis_2023_021227 crossref_primary_10_1016_j_jocn_2018_08_006 crossref_primary_10_1007_s12975_024_01261_w crossref_primary_10_23736_S0390_5616_21_05481_3 crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_105763 crossref_primary_10_1136_neurintsurg_2016_012327 crossref_primary_10_1016_j_wneu_2017_01_097 crossref_primary_10_1161_JAHA_120_018626 crossref_primary_10_1002_jmri_28234 crossref_primary_10_1016_j_wneu_2023_10_128 crossref_primary_10_3171_2018_4_JNS173221 crossref_primary_10_5469_neuroint_2018_01011 crossref_primary_10_1080_14737175_2016_1199958 crossref_primary_10_1007_s10143_020_01352_w crossref_primary_10_1007_s11517_024_03136_6 crossref_primary_10_1227_NEU_0000000000000835 crossref_primary_10_1016_j_cmpb_2023_107963 crossref_primary_10_7461_jcen_2023_E2022_10_011 crossref_primary_10_1016_j_neuroimage_2021_118216 crossref_primary_10_1016_j_wneu_2019_03_094 crossref_primary_10_3349_ymj_2021_62_11_1052 crossref_primary_10_1212_WNL_0000000000003874 crossref_primary_10_1161_STROKEAHA_120_029967 crossref_primary_10_1109_ACCESS_2018_2799307 crossref_primary_10_34067_KID_0000000000000092 crossref_primary_10_1016_j_wneu_2018_03_003 crossref_primary_10_1093_neuros_nyy161 crossref_primary_10_3174_ajnr_A7418 crossref_primary_10_3171_2019_6_JNS19704 crossref_primary_10_17802_2306_1278_2023_12_1_172_180 crossref_primary_10_1136_practneurol_2020_002521 crossref_primary_10_7887_jcns_31_74 crossref_primary_10_1016_j_acra_2021_06_013 crossref_primary_10_1016_j_jocn_2018_04_014 crossref_primary_10_1007_s00062_019_00809_w crossref_primary_10_1136_jnis_2023_021113 crossref_primary_10_1212_WNL_0000000000003865 |
Cites_doi | 10.1227/NEU.0b013e3182354d68 10.1056/NEJMoa1113260 10.3171/jns.2004.101.6.0908 10.3171/2012.11.JNS121210 10.1161/STROKEAHA.113.001838 10.1161/STROKEAHA.113.001138 10.1097/00006123-200112000-00006 10.1148/radiol.13121188 10.1097/00006123-200103000-00007 10.1016/0303-8467(93)90125-Z 10.1148/radiol.10091982 10.1016/S1474-4422(13)70263-1 10.1227/01.NEU.0000217366.02567.D2 10.1161/STROKEAHA.113.004421 10.3171/jns.2003.99.3.0447 10.1161/STROKEAHA.114.005963 10.3171/2012.7.JNS111766 10.1227/01.NEU.0000124482.03676.8B 10.1136/neurintsurg-2013-010944 10.3171/2013.3.JNS121469 10.1161/01.STR.0000199077.06390.35 10.1136/jnnp.2008.169573 10.1136/jnnp-2011-302068 10.1227/NEU.0b013e31820edbd3 10.1161/01.STR.32.2.485 10.1007/s00234-010-0804-4 10.1161/STROKEAHA.109.566018 10.3171/jns.2002.96.1.0064 10.1161/STROKEAHA.108.519165 10.3171/JNS/2008/109/8/0176 10.3171/jns.2002.97.5.1023 10.1161/STROKEAHA.109.574244 10.1007/s00701-012-1566-z 10.1007/s00234-004-1324-x 10.1016/j.jclinepi.2009.12.008 10.1227/01.NEU.0000316847.64140.81 10.1016/S1474-4422(11)70109-0 10.1136/bmj.b604 |
ContentType | Journal Article |
Copyright | 2015 American Heart Association, Inc. |
Copyright_xml | – notice: 2015 American Heart Association, Inc. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1161/STROKEAHA.114.008198 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4628 |
EndPage | 1226 |
ExternalDocumentID | 10_1161_STROKEAHA_114_008198 25757900 10.1161/STROKEAHA.114.008198 |
Genre | Multicenter Study Journal Article |
GroupedDBID | - .XZ .Z2 01R 08R 0R 123 1AW 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 55 5RE 5VS 71W 77Y 7O 7O~ AAAXR AAMOA AAMTA AAPBV AAQQT AARTV AAXQO AAYEP AAYJJ ABBUW ABFLS ABXVJ ABZAD ACDDN ACEWG ACGFS ACGOD ACWDW ACWRI ACXNZ ADACO ADBBV ADFPA ADNKB AE3 AENEX AFFNX AFUWQ AHMBA AHULI AHVBC AIJEX AJIOK AJNYG AJYGW ALMA_UNASSIGNED_HOLDINGS AMJPA ASCII AWKKM BAWUL BOYCO BQLVK C45 CS3 DIK DU5 DUNZO E.X E3Z EBS EJD EX3 F2K F2L F2M F2N F5P FL- FW0 GJ GX1 H0 H0~ H13 HZ IKYAY IN IN~ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA OGROG OHASI OK1 OL1 OLG OLH OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWW OWY OXXIT P-K P2P PQEST PQQKQ R58 RAH RHF RIG RLZ RSW S4R S4S TWZ V2I WH7 WOQ WOW X3V X3W X7M XZ YCJ YHZ YQJ Z2 ZA5 ZGI --- .3C .55 .GJ 0R~ 6PF A9M AAAAV AAGIX AAHPQ AAIQE AAJCS AAQKA AASCR AASOK AAUEB ABASU ABDIG ABJNI ABQRW ABVCZ ACCJW ACILI ACLDA ACXJB ADGGA ADHPY AE6 AEBDS AEETU AFDTB AFEXH AFSOK AGINI AHOMT AHQNM AHRYX AINUH AJNWD AJZMW AKULP ALMTX AMKUR AMNEI AOHHW AYCSE BCGUY BS7 CGR CUY CVF DIWNM ECM EEVPB EIF ERAAH FCALG GNXGY GQDEL HLJTE HZ~ IKREB IPNFZ M18 N4W NPM ODMTH OHYEH OJAPA OWBYB OWU OWV OWX OWZ T8P TEORI TSPGW VVN W3M W8F XXN XYM YFH YYP ZB8 ZZMQN AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c5198-b8a36e9f94cc7b29cdced9e3cb9e01d4b2e47f163fcbb97cab0e639926fb24c43 |
ISSN | 0039-2499 |
IngestDate | Sat Oct 26 00:28:44 EDT 2024 Fri Aug 23 01:48:50 EDT 2024 Tue Oct 15 23:55:15 EDT 2024 Thu Aug 13 19:50:28 EDT 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | PHASES follow-up unruptured aneurysm growth imaging |
Language | English |
License | 2015 American Heart Association, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5198-b8a36e9f94cc7b29cdced9e3cb9e01d4b2e47f163fcbb97cab0e639926fb24c43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.114.008198 |
PMID | 25757900 |
PQID | 1676592472 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1676592472 crossref_primary_10_1161_STROKEAHA_114_008198 pubmed_primary_25757900 wolterskluwer_health_10_1161_STROKEAHA_114_008198 |
ProviderPackageCode | OVOZU L-C C45 7O~ AARTV ADFPA OLH ASCII OLG AAMOA ODA ABZAD ABBUW JK3 ADNKB JK8 H0~ 1J1 OLV OLU JG8 OLW OLZ OLY F2K F2M F2L F2N OHASI AHVBC AJNYG FL- KMI K8S OGROG OVLEI AJIOK OPUJH V2I .XZ S4R S4S 4Q1 DUNZO OAG 4Q2 OVDNE 4Q3 AMJPA OAH OVD 71W AHULI ACEWG OB3 .Z2 N~7 IKYAY OVIDH AWKKM 40H N~B OUVQU ORVUJ X3V X3W ACDDN ACWRI BOYCO AIJEX AAXQO AAMTA AAAXR E.X OWW OCUKA OWY 01R ACXNZ OL1 ABXVJ IN~ KD2 OXXIT 77Y ACWDW JF9 FW0 |
PublicationCentury | 2000 |
PublicationDate | 2015-May |
PublicationDateYYYYMMDD | 2015-05-01 |
PublicationDate_xml | – month: 05 year: 2015 text: 2015-May |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Stroke (1970) |
PublicationTitleAlternate | Stroke |
PublicationYear | 2015 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_3_17_2 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_32_2 e_1_3_3_33_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_3_2 e_1_3_3_21_2 |
References_xml | – ident: e_1_3_3_23_2 doi: 10.1227/NEU.0b013e3182354d68 – ident: e_1_3_3_34_2 doi: 10.1056/NEJMoa1113260 – ident: e_1_3_3_13_2 doi: 10.3171/jns.2004.101.6.0908 – ident: e_1_3_3_36_2 doi: 10.3171/2012.11.JNS121210 – ident: e_1_3_3_9_2 doi: 10.1161/STROKEAHA.113.001838 – ident: e_1_3_3_31_2 doi: 10.1161/STROKEAHA.113.001138 – ident: e_1_3_3_7_2 doi: 10.1097/00006123-200112000-00006 – ident: e_1_3_3_17_2 doi: 10.1148/radiol.13121188 – ident: e_1_3_3_25_2 doi: 10.1097/00006123-200103000-00007 – ident: e_1_3_3_33_2 doi: 10.1016/0303-8467(93)90125-Z – ident: e_1_3_3_4_2 doi: 10.1148/radiol.10091982 – ident: e_1_3_3_8_2 doi: 10.1016/S1474-4422(13)70263-1 – ident: e_1_3_3_12_2 doi: 10.1227/01.NEU.0000217366.02567.D2 – ident: e_1_3_3_37_2 doi: 10.1161/STROKEAHA.113.004421 – ident: e_1_3_3_24_2 doi: 10.3171/jns.2003.99.3.0447 – ident: e_1_3_3_22_2 doi: 10.1161/STROKEAHA.114.005963 – ident: e_1_3_3_26_2 doi: 10.3171/2012.7.JNS111766 – ident: e_1_3_3_27_2 doi: 10.1227/01.NEU.0000124482.03676.8B – ident: e_1_3_3_18_2 doi: 10.1136/neurintsurg-2013-010944 – ident: e_1_3_3_16_2 doi: 10.3171/2013.3.JNS121469 – ident: e_1_3_3_15_2 doi: 10.1161/01.STR.0000199077.06390.35 – ident: e_1_3_3_28_2 doi: 10.1136/jnnp.2008.169573 – ident: e_1_3_3_5_2 doi: 10.1136/jnnp-2011-302068 – ident: e_1_3_3_39_2 doi: 10.1227/NEU.0b013e31820edbd3 – ident: e_1_3_3_21_2 doi: 10.1161/01.STR.32.2.485 – ident: e_1_3_3_29_2 doi: 10.1007/s00234-010-0804-4 – ident: e_1_3_3_3_2 doi: 10.1161/STROKEAHA.109.566018 – ident: e_1_3_3_6_2 doi: 10.3171/jns.2002.96.1.0064 – ident: e_1_3_3_11_2 doi: 10.1161/STROKEAHA.108.519165 – ident: e_1_3_3_38_2 doi: 10.3171/JNS/2008/109/8/0176 – ident: e_1_3_3_14_2 doi: 10.3171/jns.2002.97.5.1023 – ident: e_1_3_3_32_2 doi: 10.1161/STROKEAHA.109.574244 – ident: e_1_3_3_10_2 doi: 10.1007/s00701-012-1566-z – ident: e_1_3_3_35_2 doi: 10.1007/s00234-004-1324-x – ident: e_1_3_3_20_2 doi: 10.1016/j.jclinepi.2009.12.008 – ident: e_1_3_3_30_2 doi: 10.1227/01.NEU.0000316847.64140.81 – ident: e_1_3_3_2_2 doi: 10.1016/S1474-4422(11)70109-0 – ident: e_1_3_3_19_2 doi: 10.1136/bmj.b604 |
SSID | ssj0002385 |
Score | 2.5567436 |
Snippet | BACKGROUND AND PURPOSE—Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm... Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated... Background and Purpose— Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm... BACKGROUND AND PURPOSEGrowth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm... |
SourceID | proquest crossref pubmed wolterskluwer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1221 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Aneurysm, Ruptured - pathology Cerebral Angiography Cohort Studies Female Follow-Up Studies Humans Intracranial Aneurysm - pathology Male Middle Aged Predictive Value of Tests Prognosis Prospective Studies Risk Assessment Survival Analysis Treatment Outcome Young Adult |
Title | PHASES Score for Prediction of Intracranial Aneurysm Growth |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25757900 https://search.proquest.com/docview/1676592472 |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBATQtwpNwWJtyohcVw7EU8ZFLVMhYl1aG-R7TjQbSQoTVWNX8DP5jjObVBNjJeojaqT1Of4O5_PxUboVRL6giZYbz7IYIEyDqQdUMptFQB_DpQUUuiA_vwjnR6RD8fj48HgV69qaV0KR_7c2lfyP1qFe6BX3SV7Bc22QuEGfAb9whU0DNd_0vHBNAI4hPmZF2bv7oNC510aEjjTgVsJzkhHxSO9c-X56ruONm3Kb31SelgW-WnFNb2Qub3YwB6HOW54Nu-s6IsqvubrjcGrOWDNeTZ658ycNgiwVGf6KRpFS2WObq_qJvlqtGh_tWfiBJEDfHd5kpUnajRx-jEIb9xV_DW46us8jTnqyFE1lGJi687XPtbW4cZlP5tdAaeHTaN07YThK90O8FQD_OHi86f9STSN9FbHTkVrgs6hNUn8P_xcW31YrXuoF7dSdGt2bKRcQ9cxQFaV8J_ttz4diI05C6P-n3UTJkh5ve1dLpKcv1Yuu-jWJtfFEKvTqheix2gWd9DteiliRcau7qKByu6hG_O62OI-emPMy6rMywLzsjrzsvLU6puX1ZiXZczrATp6P1m8ndr1WRu2BA4f2CLgPlVhGhIpmcChTKRKQuVLESrXS4jAirAUyHsqhQiZ5MJVmtximgpMJPEfop0sz9RjZDEtxxOBm7KUJCkDxskTl3AhMAd-S4fIbgYn_mG2VIkvU8kQvWxGMAbs0wktnql8vYo9ynRVAGF4iB6ZoW0lgisaw6PdIfIujHVs-osvfeKTK77hU3SzmxXP0E5ZrNVz4KqleFGZ0W_r5Ip8 |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PHASES+Score+for+Prediction+of+Intracranial+Aneurysm+Growth&rft.jtitle=Stroke+%281970%29&rft.au=Backes%2C+Daan&rft.au=Vergouwen%2C+Mervyn+D.I.&rft.au=Tiel+Groenestege%2C+Andreas+T.&rft.au=Bor%2C+A.+Stijntje+E.&rft.date=2015-05-01&rft.issn=0039-2499&rft.eissn=1524-4628&rft.volume=46&rft.issue=5&rft.spage=1221&rft.epage=1226&rft_id=info:doi/10.1161%2FSTROKEAHA.114.008198&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_STROKEAHA_114_008198 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon |